ClinicalTrials.gov
public full text
Public Domain
Immune Checkpoint Receptors in AML-Leukemic Initiating Cells
This project aim at deciphering immune mechanisms that allow the immunoescape of AML initiating cells.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML#471461
- Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity#885440
- Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors#916602
- Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia#833601
- Infection and Tumour Antigen Cellular Therapy#832848
Record · ID 1095141
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive